A very special thanks to "the street gang" PhillyDan, andybaron, Gaucho, Psych Analyst, tahalb and anyone else I may have missed for your INVALUABLE contributions to SA on Lorcaserin.
You all helped me get into this trade, which I could not have done without you.
An extra special thanks to PhillyDan and andybaron (and anyone else I may have missed) for taking on Feurstein over at TheStreet.com and keeping me in the trade when I got scared.
I owe it all to you guys, my favorite "street gang". May Lorcaserin bless and improve the lives of all who need it.
Here's to finding the next ARNA!! THANK YOU ALL!!!!!!!
Spain Bailout, Other Indicators Say: Be Open To Stock Rally [View article]
IC. Spain will not collapse tomorrow so the slowing of the US economy, the hard landing in China, the depression in Europe and the collapse of commodity prices mean nothing.
Arena Pharmaceuticals' Outlook Hinges On Success Of Lorcaserin [View article]
I wouldn't count on a sharp rise before May 10th. Feuerstein's article did so much technical damage to the stock that it will likely languish until there is positive news from the FDA. Too many people got hurt on the collapse from $3.50 to just over $2, and it looks like even some of the larger players have gotten cold feet and are exiting the stock as selling pressure continues. This does give you a cheap point to get in however if you believe there will be an FDA recommendation on May 10.
3 Hot Biotech Stocks To Boost Your Portfolio [View article]
Not sure how you missed the latest flap about ARNA. Biotech guru Adam Feuerstein from TheStreet.com has proclaimed that ARNA's drug Lorcaserin is doomed to failure. In response to Feuerstein's articles, ARNA has sold off about 40% to just over $2.
A cease and desist order has been sent to Feuerstein asking him to retract his alleged defamation of Lorcaserin and cease further activity. Feuerstein has refused to retract and wrote another article here. http://bit.ly/JmSMO8
I would be interested in hearing your rebuttal to Feuerstein's articles. It is the opinion of some legal counsel that Feuerstein has crossed legal limits in the timing and content of his articles proclaiming ARNA's own data states they will not pass FDA approval for Lorcaserin.
The problem with contraETF's is that in a sharp market sell-off there could be large gaps that wouldn't be captured by the ETF. I think they're better for day trading, not position trading.
Eurozone Update: It's Not As Bad As Many Think [View article]
Trunkbow: Capitalizing On The China Mobile Revolution [View article]
The Obesity Race: Update, Part 1 [View article]
You all helped me get into this trade, which I could not have done without you.
An extra special thanks to PhillyDan and andybaron (and anyone else I may have missed) for taking on Feurstein over at TheStreet.com and keeping me in the trade when I got scared.
I owe it all to you guys, my favorite "street gang". May Lorcaserin bless and improve the lives of all who need it.
Here's to finding the next ARNA!! THANK YOU ALL!!!!!!!
Spain Bailout, Other Indicators Say: Be Open To Stock Rally [View article]
Spain Bailout, Other Indicators Say: Be Open To Stock Rally [View article]
Spain Bailout, Other Indicators Say: Be Open To Stock Rally [View article]
We're talking SENTIMENT here, my friend. When governments print monopoly money, markets listen.
Apple: It's The Week We've All Been Waiting For (Part 1) [View article]
I wonder how much longer Apple will continue to give away easy money?
I'm willing to participate on the upside, but relax? No way.
Arena Pharmaceuticals' Outlook Hinges On Success Of Lorcaserin [View article]
3 Hot Biotech Stocks To Boost Your Portfolio [View article]
A cease and desist order has been sent to Feuerstein asking him to retract his alleged defamation of Lorcaserin and cease further activity. Feuerstein has refused to retract and wrote another article here.
http://bit.ly/JmSMO8
I would be interested in hearing your rebuttal to Feuerstein's articles. It is the opinion of some legal counsel that Feuerstein has crossed legal limits in the timing and content of his articles proclaiming ARNA's own data states they will not pass FDA approval for Lorcaserin.
Signs Of A Stock Market Top? [View article]
Signs Of A Stock Market Top? [View article]
Arena Pharmaceuticals: A Stock For Aggressive Investors [View article]
Tempting Tuesday: Baa, Baa To The Sheeple [View article]
A Reasoned Case For Qnexa Approval [View article]
SPY Calendar Put Spread [View article]